KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Work In Process (2021)

Ginkgo Bioworks Holdings' Work In Process history spans 1 years, with the latest figure at $50000.0 for Q4 2021.

  • For Q4 2021, Work In Process changed N/A year-over-year to $50000.0; the TTM value through Dec 2021 reached $50000.0, changed N/A, while the annual FY2021 figure was $50000.0, N/A changed from the prior year.
  • Work In Process reached $50000.0 in Q4 2021 per DNA's latest filing, down from $163000.0 in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $163000.0 in Q3 2021 to a low of $50000.0 in Q4 2021.